Single Versus Dual Antiplatelet Therapy following Left Atrial Appendage Occlusion in Patients With High Bleeding Risk-Reference-Cited by-同舟云学术

Single Versus Dual Antiplatelet Therapy following Left Atrial Appendage Occlusion in Patients With High Bleeding Risk

Published:2022-09 Issue:9 Volume:47 Page:101269
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Mhanna Mohammed^ORCID,Beran Azizullah,Al-Abdouh Ahmad,Jabri Ahmad,Al-Aaraj Ahmad,Sajdeya Omar,Abuhelwa Ziad,Khokher Waleed,Bhuta Sapan,Burmeister Cameron J.,Eltahawy Ehab A

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference27 articles.

1. Direct oral anticoagulants versus warfarin in morbidly obese patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis;Mhanna;Am J Ther,2021

2. Stroke and thromboembolism prevention in atrial fibrillation;Jame;Heart,2020

3. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (percutaneous left atrial appendage transcatheter occlusion) study;Block;JACC: Cardiovasc Interv,2009

4. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis;Holmes;J Am Coll Cardiol,2015

5. Postprocedural antithrombotic therapy following left atrial appendage occlusion: no longer adrift in uncertainty?;Chew;Circ Cardiovasc Interv,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper;Europace;2024-01-31

2. Left Atrial Appendage Occlusion and Post-procedural Antithrombotic Management;Journal of Clinical Medicine;2024-01-30

3. Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group;Thrombosis Research;2024-01